Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial.

Saved in:
Bibliographic Details
Title: Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial.
Authors: Biganzoli G; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy., Isnaldi E; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium., Richard F; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium., Marano G; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy., Boracchi P; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy., Maetens M; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium., Floris G; KU Leuven, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, Leuven, Belgium; University Hospitals Leuven, Department of Pathology, Leuven, Belgium., Neven P; Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ-Leuven, KU Leuven, Leuven, Belgium., Jerusalem G; Medical Oncology Department, CHU Liège, Liège University, Liège, Belgium., Munzone E; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy., Hitre E; Department of Medical Oncology and Clinical Pharmacology 'B', National Institute of Oncology, Budapest, Hungary., Gombos A; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Thompson A; Division of Surgical Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, USA., Aebi S; Division of Medical Oncology, Cancer Center, Lucerne Cantonal, Hospital, Lucerne, Switzerland; Faculty of Medicine, University of Bern, Bern, Switzerland., Kammler R; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland., Dell'Orto P; IBCSG Central Pathology Office, Milan, Italy., Viale G; IBCSG Central Pathology Office, Milan, Italy; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy., Regan MM; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Colleoni M; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy., Biganzoli E; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium., Desmedt C; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium. Electronic address: christine.desmedt@kuleuven.be.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jun 03; Vol. 222, pp. 115438. Date of Electronic Publication: 2025 Apr 17.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2025.115438